What is the pathology of retinitis pigmentosa?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pathology of Retinitis Pigmentosa

Retinitis pigmentosa is a hereditary retinal dystrophy characterized by progressive degeneration of rod and cone photoreceptors, followed by secondary changes in the retinal pigment epithelium, retinal glia, inner retinal neurons, blood vessels, and optic nerve head 1.

Primary Pathologic Process

The fundamental pathology begins with photoreceptor cell death, predominantly affecting rod cells initially, with cone cells becoming involved simultaneously or later in the disease course 2. This primary degenerative process is driven by mutations in over 90 identified genes, many of which encode proteins involved in the phototransduction pathway 3.

Cellular-Level Changes

The molecular pathophysiology involves:

  • Genetic impairment of phototransduction proteins - mutations affect the photoexcitation and inhibition processes within photoreceptor cells 3
  • Alternative splicing dysregulation - disruption of precise splicing patterns leads to widespread mis-splicing of photoreceptor-specific genes, particularly critical given that >95% of human multi-exon genes undergo alternative splicing 4
  • Progressive photoreceptor loss - rod photoreceptors degenerate first, followed by cone cell dysfunction 1

Secondary Pathologic Changes

Following the primary photoreceptor degeneration, a cascade of secondary alterations occurs 1:

Retinal Pigment Epithelium (RPE)

  • Hypo- and hyperpigmentation ("salt-and-pepper" appearance)
  • Retinal granularity
  • Bone spicule formation - the pathognomonic finding representing RPE migration into the neurosensory retina

Vascular Changes

  • Retinal vessel narrowing and attenuation
  • Progressive vascular incompetence

Optic Nerve

  • Waxy pallor of the optic disc
  • Degenerative changes in the optic nerve head

Inner Retinal Structures

  • Alterations in retinal glia
  • Degenerative changes in inner retinal neurons
  • Intraretinal degenerative cystic changes - typically in the inner nuclear layer, ranging from slit-like cysts to larger cystoid cavities 5

Structural Imaging Correlates

On OCT, the pathologic progression manifests as 5:

  • Ellipsoid layer disruption - earliest detectable change
  • Attenuation and disorganization of outer nuclear layer
  • Progressive loss of outer nuclear and ellipsoid layers
  • Central preservation of foveal ellipsoid band (late finding)
  • Tapered parafoveal transition zone
  • Outer retinal tubulations overlying areas of RPE loss

Clinical Pitfall

Bone spicule formation is characteristic of inherited retinal dystrophies like RP but is very atypical for autoimmune retinopathy - this distinction is critical when differentiating RP from its mimics 5. The presence of bone spicules strongly favors an inherited etiology over autoimmune or inflammatory causes.

Genetic Heterogeneity

The pathology funnels through diverse genetic mechanisms into a common end-stage phenotype 6. Inheritance patterns include autosomal recessive (80%), autosomal dominant (15%), X-linked (~1%), and mitochondrial transmission 7. This genetic heterogeneity explains the phenotypic diversity observed clinically despite similar pathologic endpoints 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.